Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial. (nature.com)

Authors: Yap TA … Gan L Journal: Nature Medicine Published: 2026-03-01 DOI: https://doi.org/10.1038/s41591-025-04157-w